| View |
|
DRP-11764
|
Paracetamol + Phenylephrine Hydrochloride + Dextromethorphan Hydrobromide
|
None
|
325 mg/25 mg/10 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
-
|
27 April 2022
|
16 February 2026
|
| View |
|
DRP-11762
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
None
|
125 mg/6.25 mg/500 mcg per 5 mL
|
Syrup
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
-
|
27 April 2022
|
16 February 2026
|
| View |
|
DRP-11763
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
None
|
500 mg/25 mg/2 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
27 April 2022
|
16 February 2026
|
| View |
|
DRP-11057-01
|
Clopidogrel
|
Flavix
|
75 mg
|
Film-Coated Tablet
|
Platelet Aggregation Inhibitor
|
Centurion Laboratories Pvt. Ltd.
|
India
|
-
|
26 April 2022
|
20 January 2027
|
| View |
|
DRP-11751
|
Gliclazide
|
None
|
80 mg
|
Modified-Release Tablet
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
-
|
26 April 2022
|
01 October 2025
|
| View |
|
DRP-2392-02
|
Amoxicillin (as trihydrate)
|
Giomox
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
09 November 2024
|
19 January 2030
|
| View |
|
DRP-6343-02
|
Aciclovir
|
Klovir
|
400 mg
|
Capsule
|
Antiviral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
27 April 2023
|
05 April 2028
|
| View |
|
DRP-8300-08
|
Rosuvastatin (as calcium)
|
Rosalta
|
20 mg
|
Film-Coated Tablet
|
Anti-hypercholesterolemia/Anti-dyslipidemia
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
09 March 2024
|
07 August 2029
|
| View |
|
DRP-8584-14
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
ZOLE-DONE
|
40 mg/30 mg
|
Modified-Release Capsule
|
Proton Pump Inhibitor/Gastrokinetic
|
Theon Pharmaceuticals Limited
|
India
|
-
|
25 April 2022
|
18 December 2024
|
| View |
|
DRP-11746
|
Paracetamol + Orphenadrine Citrate
|
Tanafen
|
450 mg/35 mg
|
Tablet
|
Analgesic / Antipyretic / Muscle Relaxant
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
18 October 2023
|
26 February 2029
|
| View |
|
DRP-11747
|
Capecitabine
|
Capetero 500
|
500 mg
|
Film-Coated Tablet
|
-
|
Hetero Labs Limited (Unit VI)
|
India
|
-
|
25 April 2022
|
12 January 2027
|
| View |
DRP-11748_PI_01.pdf
|
DRP-11748
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Co-Altria Ped
|
5mg/2.5mg
|
Chewable Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
-
|
25 April 2022
|
26 January 2025
|
| View |
DRP-11749_PI_01.pdf
|
DRP-11749
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Co-Altria Ped
|
5mg/5mg
|
Chewable Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
-
|
25 April 2022
|
26 January 2025
|
| View |
|
DRP-1391-03
|
Fenofibrate
|
Triden
|
160 mg
|
Tablet
|
Lipid Modifying Agent (Fibrate)
|
Sun Pharmaceuticals Industries Limited
|
India
|
Renewal
|
20 March 2024
|
23 April 2029
|
| View |
|
DRP-3710-06
|
Telmisartan
|
Oppisartan-80
|
80 mg
|
Tablet
|
Angiotensin II Antagonist
|
Stallion Laboratories Pvt. Ltd
|
India
|
-
|
22 April 2022
|
29 March 2027
|
| View |
|
DRP-4709-01
|
Cefixime (as trihydrate)
|
Unbranded
|
200 mg
|
Film-Coated Tablet
|
Antibacterials (Cephalosporins)
|
Brawn Laboratories Limited
|
India
|
Renewal
|
10 March 2023
|
13 September 2028
|
| View |
|
DRP-5460-03
|
Metronidazole
|
Medicazol
|
5 mg/mL (500 mg/100 mL)
|
Solution For I.V. Infusion
|
ANTIBACTERIAL (NITROIMIDAZOLE)/ ANTIPROTOZOAL (AMEBICIDE)
|
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
29 May 2023
|
31 July 2028
|
| View |
|
DRP-6344-02
|
Aciclovir
|
Klovir
|
200 mg
|
Capsule
|
Antiviral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
27 April 2023
|
05 April 2028
|
| View |
|
DRP-6572-01
|
Letrozole
|
None
|
2.5 mg
|
Film- Coated tablet
|
Antineoplastic (Aromatase Inhibitor)
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
-
|
22 April 2022
|
16 March 2026
|
| View |
|
DRP-11728
|
Co-Amoxiclav
|
Aclav-625
|
625 mg
|
Film-Coated Tablet
|
-
|
Giyaan Pharma Pvt. Ltd
|
India
|
-
|
22 April 2022
|
29 October 2026
|